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u n I V e R s a l  H P l c  a n a lY s I s  f o R  c o u n t e R f e I t  m e D I c at I o n :
A Partnership of Purdue University and the Kilimanjaro School of Pharmacy
ABSTRACT
Counterfeit drugs pose a serious problem in Tanzania and 
other countries in Africa. These drugs are very similar to 
the real product in size, shape, and packaging. However, 
counterfeit drugs have less to none of the active 
pharmaceutical ingredient, rendering them essentially 
useless. Patients and medical practitioners often are 
unable to distinguish between the real medication and the 
counterfeit version, meaning that a patient’s condition 
may go untreated. Research conducted by the Global 
Development Team is aimed at developing a simple way 
to distinguish between real and counterfeit drugs, as well 
as to develop a universal method that can systematically 
analyze a wide variety of drug compounds. Purdue 
students describe the development of training materials 
and plans to travel to the Kilimanjaro School of 
Pharmacy in Tanzania to educate students and faculty on 
how to utilize this method.
INTRODUCTION
It is important that patients actually receive the 
medication that they were prescribed. Many Western 
cultures take this for granted, but in other parts of the 
world there is a serious problem with patients receiving 
counterfeit drugs. Countless lives have been lost due 
to ineffective treatment of diseases or consumption of 
potentially harmful substances. The U.S. Food and Drug 
Administration estimates that approximately 450,000 
malarial deaths worldwide are the result of counterfeit 
medication (Karunamoorthi, 2014). It has been estimated 
that in the developing world, preventable deaths and 
diseases were attributed to the falsifi cation of nearly one-
quarter of all pharmaceuticals, according to the World 
Health Organization (Bagozzi, 2003). With such high 
incidence of substandard medication, many patients have 
developed a strong distrust in pharmaceuticals.
One method to combat the counterfeit drug problem 
includes paper analytical devices (PADs) created by 
scientists at the University of Notre Dame (Rosenwald, 
2013). These strips of paper quickly detect whether a 
medication is counterfeit. They are easy to distribute 
and use, making them popular. Unfortunately, each 
PAD must be specifi c to each drug and the strips are 
not strong indicators of how much of the API is present 
in the product. Results from this project could be used 
to confi rm the actual percent of active drug product in 
a compound, while the PADs give a broad indication 
of whether it is counterfeit. Additional devices such as 
the Zaman’s PharmaCheck are able to indicate relative 
percent of active drug product, but also are specifi c to 
each drug (Dwortzan, 2013).
The Global Development Team, led by Drs. Stephen 
Byrn and Kari Clase (Purdue University three-credit 
course: GEP 40000), aims to develop a universal 
method for detecting counterfeit medications. 
Engineering and pharmacy students work together on 
this interdisciplinary project in this course. The project 
partner is the Kilimanjaro School of Pharmacy in 
Tanzania. When developed, this method will encompass 
a variety of medications rather than one procedure per 
each drug type. The project partner could test multiple 
drugs quickly and effectively. Ongoing goals of the 
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project will be to create methods for an increasing 
number of drug products, assemble operational detection 
instruments including software and computers, and 
develop training materials to implement the project at 
the Kilimanjaro School of Pharmacy in Tanzania.
METHODOLOGY
In order to determine which drugs to initially focus 
on, the team studied the World Health Organization’s 
(WHO) essential medicines list. The next consideration 
was the relevance of the drugs in Tanzania. To find 
out which pharmaceuticals were often used, the 
team researched common diseases and associated 
prescriptions in the area. We also examined drugs 
cited as most often counterfeited in Tanzania. After 
determining a list of possible drugs to test, the project 
advisors and partners were consulted for additional 
insight into which drugs should be considered for 
preliminary analysis. Five drugs of varied indications 
were selected to develop a basic detection method: 
amoxicillin, hydrochlorothiazide, lumefantrine, 
mefloquine, and quinine.
There are numerous methods for detecting the presence 
of specific chemicals within a compound, including 
thin-layer chromatography, mass spectrometry, gas 
chromatography, and many others. High-performance 
liquid chromatography (HPLC) is one of the most 
common and sensitive analytical techniques used in the 
pharmaceutical industry and is a quality metric in most 
industrial chemical production facilities. It works by 
separating compounds through a pressurized column 
based on their physical properties, such as lipophilicity 
and polarity. HPLC was chosen as the basis for this work 
because the variables can be manipulated in such a way 
that an almost unlimited number of drugs can be tested 
and identified. This option also allows for all five of the 
selected drugs to be analyzed utilizing very few additional 
resources. Agilent 1100 series HPLC instruments and 
software packages travel well and were provided through 
the generous donation of Merck & Co., Inc. (Figure 1).
The United States Pharmacopeia (USP) is responsible 
for setting and publishing the standards for testing the 
quality of all medications. The USP contains verified 
methods for analyzing drugs, including the quantified 
best HPLC procedures for each of the five drugs 
tested by this team. While these methods are both 
accurate and ideal, they often are very different for 
each medication. The team initially performed the USP 
protocol for each of the five drugs being considered 
to verify HPLC methods and instruments. We noticed 
that a select few common solvents and columns were 
used for the different methods. The team used this 
information and the available materials to determine that 
the Agilent Zorbax SB C18 column would be applied 
to all procedures. This column was readily available 
in the lab and is a common size and type of column. 
Later testing indicates that this column is suitable for 
the methods developed in the project. The commonality 
in USP protocols also helped the team decide to focus 
universal efforts on creating methods using three select 
solvents: methanol, acetonitrile, and 0.05 M monobasic 
potassium phosphate. Extraction procedures are in 
development for each of the five drugs being studied. 
These will allow the instrument to output values for the 
active pharmaceutical ingredient, if it is present, and will 
eliminate most excipients in the full drug products that 
function to stabilize and deliver the medication but that 
are not relevant to this project.
Methods for assembling the provided HPLC instrument 
are in development. The team also is creating training 
materials and a troubleshooting guide for the students 
and staff at the Kilimanjaro School of Pharmacy.
BRIEF RESULTS
The team had to alter USP protocol to comply with 
the project’s three-solvent system. Most USP methods 
require some form of salt, which was replaced with 
the potassium phosphate buffer in all of the project 
methods. Results indicate that these replacements still 
generate acceptable responses as indicated in sample 
chromatograms found in Figures 2 and 3.
The potassium phosphate solvent has been studied at 
varied pH levels and has thus far shown acceptable 
results for four of the five drugs when the natural pH 
Figure 1. High-performance liquid chromatography unit at the 
Kilimanjaro School of Pharmacy.
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Figure 2. HPLC chromatogram for USP-grade amoxicillin using the developed universal method indicates a significant peak at 
approximately a 5.5 minute elution time, indicating purity and efficacy of the method.
Figure 3. HPLC chromatogram for USP-grade hydrochlorothiazide using the developed universal method indicates a significant peak at 
approximately a 15.4 minute elution time, indicating purity and efficacy of the method.
level is used. This is ideal because it lowers cost and 
time required for creating the buffer. All methods for the 
five pure drug compounds using the project’s universal 
approach have been verified. Methods for extraction are 
developed and in process of verification.
FUTURE WORK
In order to further fulfill the goals of this project, 
members of this Global Development Team will take the 
work it has completed thus far to the Kilimanjaro School 
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of Pharmacy in Tanzania. Three students will travel to 
the Kilimanjaro School of Pharmacy in August 2015. 
The students will stay at the school for approximately 
one week, where they will implement the project and 
interact with the partners. Activities include constructing 
one of the Agilent 1100 series HPLC units donated to the 
team by Merck & Co., Inc., and upon successful setup 
of this HPLC unit, the team will train members of the 
Kilimanjaro School of Pharmacy on how to successfully 
replicate the setup process. The team also will train 
members of the school in how to run and troubleshoot 
the standard and extraction methods developed for 
amoxicillin, hydrochlorothiazide, lumefantrine, 
mefloquine, and quinine.
Because the major aim of this project is to create a 
universal method for detecting counterfeit medications, 
it is desired to continue the work of this Global 
Development Team at least into the 2015–2016 
academic school year. Members of this team hope to 
create methods to detect other commonly counterfeited 
medications in Tanzania. By maintaining other 
parameters of this project, such as limiting the number 
of solvents used in the HPLC, this project will become 
even more universal, allowing for the testing of as many 
drugs as possible.
Future work will expand the method to include 
more commonly used and commonly counterfeited 
medications as well as to maintain training and 
troubleshoot materials used at the Kilimanjaro School of 
Pharmacy.
As mentioned previously, there are other very specific 
means of detecting counterfeit drugs. This project aims 
to eventually achieve a universal method for HPLC drug 
analysis that will clearly identify drugs that are not as 
they are labeled. If this goal is achieved, students and 
faculty can be trained to identify counterfeit drugs. This 
will result in rebuilding trust in pharmaceuticals, and, 
most importantly, it will save lives.
FEEDBACK
If we were to begin again, we would make a few 
changes. First, we would seek additional funding at the 
start. The majority of the project funds came from a 
single private campus laboratory. While these donations 
were greatly appreciated, had we received more grants, 
more solvents could have been purchased, along with a 
single devoted laptop to make the project more efficient 
and streamlined. Another important area of focus would 
have been on early and increased communication with 
the Kilimanjaro School of Pharmacy. Learning what 
supplies and resources they have access to, the best 
way for us to teach them how to utilize our findings, 
and more communication about the Tanzanian culture 
all would have been very beneficial. There also have 
been roadblocks for the team in regard to the HPLC 
and computer utilization. Due to limited resources, 
we had to share equipment with other groups in our 
laboratory. Had we had a laptop and HPLC system 
devoted to our team, we would have had more time 
to complete relevant testing that otherwise was spent 
waiting for an available instrument or restoring the 
settings for our tests and methods. Finally, it would 
have been beneficial for new members and returning 
members to have comprehensive training on the 
instrument during onboarding, as much of the training 
was through self-learning and discovery.
EVALUATION
This project taught all of the project members many 
invaluable lessons, with many more surely to follow. 
Working with an analytical instrument has taught us 
about a process used in research laboratories all over the 
world. Learning how to troubleshoot computer problems 
and fix problems as they arise is important in most 
career paths. This project has given us an opportunity to 
protect, improve, and save lives.
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